The Business Times

Take this app and call me in the morning

Published Mon, Mar 19, 2018 · 06:12 AM
Share this article.

[NEW YORK] Health tech companies are making a big push to digitise medicine, introducing novel tools like digital pills that track when patients take their drugs and smart spoons that can automatically adjust to hand tremors.

Now they want some patients to get prescription treatments from the app store as well.

Later this year, doctors treating patients addicted to substances like cocaine and amphetamines will be able to prescribe Reset, an app that gives patients lessons to help them modify their behaviour. The Food and Drug Administration cleared it in September as the first mobile medical app to help treat substance-use disorders.

"It's all the things you would traditionally associate with a pill or any other medication," said Dr Corey McCann, the chief executive of Pear Therapeutics, the startup behind Reset.

"But it just so happens to be a piece of software."

Pear Therapeutics is at the forefront of a new category of medical treatment, offering what company executives call "prescription digital therapeutics".

These products, they say, are medical apps that have been studied in randomised clinical trials, cleared by the FDA, require a doctor's prescription and allow doctors to track patients' progress.

Companies like Pear are trying to stand apart in a global market of more than 318,000 health apps by arguing that their products provide assurance of effectiveness and safety.

A few medical experts, however, argue that the apps, while promoting themselves as a new medical therapy, are essentially just repackaging and rebranding existing treatments. They note that behavioural therapy done on a computer, instead of on a smartphone, was already a long-standing health treatment and backed by research.

Anyone will be able to download the Reset app. But to get it to work on a smartphone, patients must enter a prescription access code. The FDA cleared the app to be used in conjunction with outpatient therapy.

In clinical trial results that Pear submitted to the FDA, substance-abuse patients who used online therapy lessons had higher abstinence rates after nine to 12 weeks than patients who had not used them.

However, six months after the study, abstinence rates among the two patient groups were about the same.

NYTIMES

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here